Published in Br J Dermatol on November 01, 1994
Critical role of mast cell chymase in mouse abdominal aortic aneurysm formation. Circulation (2009) 1.43
Collagenofibrotic glomerulopathy-a review. Clin Kidney J (2012) 1.03
11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects. J Clin Invest (2013) 0.97
Glucocorticoids induce a near-total suppression of hyaluronan synthase mRNA in dermal fibroblasts and in osteoblasts: a molecular mechanism contributing to organ atrophy. Biochem J (2000) 0.95
Demonstration of increased collagen synthesis in irradiated human skin in vivo. Br J Cancer (1998) 0.89
Effects of TRAP-1-like protein (TLP) gene on collagen synthesis induced by TGF-β/Smad signaling in human dermal fibroblasts. PLoS One (2013) 0.87
The impact of chemotherapy and radiation therapy on the remodeling of acellular dermal matrices in staged, prosthetic breast reconstruction. Plast Reconstr Surg (2015) 0.82
Reversal of abnormal collagen production in Crohn's disease intestinal biopsies treated with regenerating agents. Gut (2004) 0.82
Comparison between laser therapy and non-surgical therapy for periodontitis in rats treated with dexamethasone. Lasers Med Sci (2009) 0.80
Large increases in adipose triacylglycerol flux in Cushingoid CRH-Tg mice are explained by futile cycling. Am J Physiol Endocrinol Metab (2012) 0.79
Remodeling Characteristics and Collagen Distributions of Biologic Scaffold Materials Biopsied From Postmastectomy Breast Reconstruction Sites. Ann Plast Surg (2015) 0.78
The unexpected anabolic phenotype and extended longevity of skin fibroblasts after chronic glucocorticoid excess. Dose Response (2006) 0.75
Rapid Growth of Dermatofibrosarcoma Protuberans Associated with Bilateral Adrenalectomy for Cushing's Syndrome. Case Rep Dermatol (2011) 0.75
Disentangling the effects of circulating IGF-1, glucose, and cortisol on features of perceived age. Age (Dordr) (2015) 0.75
Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem (1990) 2.51
Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem (1993) 2.44
7-S collagen: characterization of an unusual basement membrane structure. Eur J Biochem (1980) 2.19
Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen. Lancet (1993) 2.09
Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem (1988) 2.01
Macromolecular structure of basement membrane collagens. FEBS Lett (1981) 1.96
Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids. J Pediatr (1998) 1.94
Type V collagen as the target for type-3 fimbriae, enterobacterial adherence organelles. Mol Microbiol (1990) 1.94
Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency. Circulation (1997) 1.93
Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int (2001) 1.88
The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein. Mol Microbiol (1989) 1.87
The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans. Am J Pathol (1998) 1.68
The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res (2003) 1.68
Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res (1993) 1.57
Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake. Gastroenterology (1990) 1.56
Occult neurofibroma and increased S100 protein in the skin of patients with neurofibromatosis type 1: new insight to the etiopathomechanism of neurofibromas. Arch Dermatol (2000) 1.56
Structural diversity and domain composition of a unique collagenous fragment (intima collagen) obtained from human placenta. Biochem J (1983) 1.55
Aberrant type I and type III collagen gene expression in human breast cancer in vivo. J Pathol (1998) 1.53
Biosynthesis of collagen and its alterations in pathological states. Med Biol (1976) 1.42
Collagen metabolites in the prediction of response to GH therapy in short children. Eur J Endocrinol (1997) 1.40
Laminin. Methods Enzymol (1982) 1.37
Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Br J Cancer (1992) 1.34
Assay of collagen-galactosyltransferase and collagen-glucosyltransferase activities and preliminary characterization of enzymic reactions with transferases from chick-embryo cartilage. Eur J Biochem (1975) 1.32
Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells. Biochem J (1997) 1.30
Atrial extracellular matrix remodelling in patients with atrial fibrillation. J Cell Mol Med (2008) 1.28
Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects. J Hepatol (1995) 1.27
Activities of prolyl hydroxylase, lysyl hydroxylase, collagen galactosyltransferase and collagen glucosyltransferase in the liver of rats with hepatic injury. Biochem J (1974) 1.25
Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease. Eur J Clin Invest (1985) 1.22
Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem (1996) 1.22
Synthesis of type I collagen in healing wounds in humans. Ann Surg (1991) 1.19
Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest (1988) 1.19
Prolyl 3-hydroxylase: partial characterization of the enzyme from rat kidney cortex. Eur J Biochem (1977) 1.15
Characterization of a hyaluronan receptor on rat sinusoidal liver endothelial cells and its functional relationship to scavenger receptors. Hepatology (1999) 1.14
Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells. Biochem J (1990) 1.12
Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K. Bone (2000) 1.12
Ichthyosis hystrix (Curth-Macklin). Light and electron microscopic studies performed before and after etretinate treatment. Arch Dermatol (1984) 1.11
Isolation and characterization of pepsin fragments of laminin from human placental and renal basement membranes. Biochem J (1981) 1.10
Aminoterminal propeptide of type III procollagen in serum during wound healing in human beings. Surgery (1990) 1.08
Partial purification and characterization of chick-embryo prolyl 3-hydroxylase. Biochem J (1979) 1.08
Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics. Bone Miner (1994) 1.07
A new method to measure type I and III collagen synthesis in human skin in vivo: demonstration of decreased collagen synthesis after topical glucocorticoid treatment. J Invest Dermatol (1992) 1.07
Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer. Br J Cancer (1995) 1.06
Collagen biosynthesis in systemic scleroderma: regulation of posttranslational modifications and synthesis of procollagen in cultured fibroblasts. J Invest Dermatol (1985) 1.06
Transdermal oestrogen therapy protects postmenopausal liver transplant women from osteoporosis. A 2-year follow-up study. J Hepatol (2001) 1.06
Collagen biosynthesis enzymes in serum and hepatic tissue in liver disease. I. Prolyl hydroxylase. Eur J Clin Invest (1979) 1.05
Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis. Ann Rheum Dis (1993) 1.05
72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: a study by in situ hybridization. J Histochem Cytochem (1994) 1.05
Analysis of extracellular matrix proteins in biological fluids. Methods Enzymol (1987) 1.04
Hyperglycemic glucose concentrations up-regulate the expression of type VI collagen in vitro. Relevance to alterations of peripheral nerves in diabetes mellitus. Am J Pathol (1993) 1.04
Pachydermoperiostosis: analysis of the connective tissue abnormality in one family. J Am Acad Dermatol (1994) 1.04
Immunohistochemical study of type I collagen and type I pN-collagen in benign and malignant ovarian neoplasms. Cancer (1995) 1.04
Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma. Br J Cancer (1996) 1.03
Hydroxylation of lysine and glycosylation of hydroxylysine during collagen biosynthesis in isolated chick-embryo cartilage cells. Biochem J (1976) 1.03
Glucosylation of galactosylhydroxylysyl residues in collagen in vitro by collagen glucosyltransferase. Inhibition by triple-helical conformation of the substrate. Eur J Biochem (1975) 1.03
Collagen glucosyltransferase. Partial purification and characterization of the enzyme from whole chick embryos and chick-embryo cartilage. Eur J Biochem (1976) 1.03
Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen. Br J Dermatol (1992) 1.03
Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer. Clin Cancer Res (2001) 1.02
Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts. Endocrinology (2001) 1.02
Biochemical markers of bone metabolism. Ann Med (1993) 1.01
Increase in circulating basement membrane antigens in diabetic rats and effects of insulin treatment. Diabetologia (1982) 1.00
Separation of prolyl 3-hydroxylase and 4-hydroxylase activities and the 4-hydroxyproline requirement for synthesis of 3-hydroxyproline. Biochem Biophys Res Commun (1976) 0.99
Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas. Am J Pathol (1993) 0.99
Sensitive radioimmunoassays for 7 S collagen and laminin: application to serum and tissue studies of basement membranes. Anal Biochem (1981) 0.99
Progressive ovarian carcinoma induces synthesis of type I and type III procollagens in the tumor tissue and peritoneal cavity. Cancer Res (1993) 0.98
A rapid assay for prolyl 3-hydroxylase activity. Anal Biochem (1978) 0.98
Type I collagen degradation product in serum of patients with early rheumatoid arthritis: relationship to disease activity and radiological progression in a 3-year follow-up. Br J Rheumatol (1994) 0.98
Basal lamina glycoproteins laminin and type IV collagen are assembled into a fine-fibered matrix in cultures of a teratocarcinoma-derived endodermal cell line. Exp Cell Res (1982) 0.97
Lymphatic clearance of synovial fluid in conscious pigs: the aminoterminal propeptide of type III procollagen. Eur J Clin Invest (1993) 0.97
Effect of hepatic injury on prolyl 3-hydroxylase and 4-hydroxylase activities in rat liver and on immunoreactive prolyl 4-hydroxylase concentrations in the liver and serum. Biochem J (1978) 0.97
Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator. Am Heart J (1996) 0.97